Structures by: Narayana B.
Total: 474
2-methylimidazolium picrate
C4H7N2,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 1 o235
a=7.0983(9)Å b=21.644(2)Å c=8.1583(9)Å
α=90.00° β=100.327(12)° γ=90.00°
2-Bromo-1-(3-nitrophenyl)ethanone
C8H6BrNO3
Acta Crystallographica Section E (2011) 67, 1 o29-o30
a=8.8259(7)Å b=8.8651(8)Å c=11.6775(8)Å
α=74.691(7)° β=75.174(7)° γ=78.681(7)°
1-(10<i>H</i>-Phenothiazin-2-yl)ethanone
C14H11NOS
Acta Crystallographica Section E (2011) 67, 2 o430-o431
a=14.3445(18)Å b=5.5425(7)Å c=15.694(2)Å
α=90.00° β=114.494(2)° γ=90.00°
(2<i>E</i>)-3-(3-Bromo-4-methoxyphenyl)-1-(pyridin-2-yl)prop-2-en-1-one
C15H12BrNO2
Acta Crystallographica Section E (2011) 67, 2 o352-o353
a=26.3402(13)Å b=3.8906(2)Å c=27.5826(17)Å
α=90.00° β=113.892(5)° γ=90.00°
3,5-Bis(4-methoxyphenyl)-1-phenyl-4,5-dihydro-1<i>H</i>-pyrazole
C23H22N2O2
Acta Crystallographica Section E (2011) 67, 2 o328-o329
a=9.4788(5)Å b=10.1893(6)Å c=19.9139(10)Å
α=90° β=92.296(4)° γ=90°
(2<i>E</i>)-3-[4-(Dimethylamino)phenyl]-1-(4-fluorophenyl)prop-2-en-1-one
C17H16FNO
Acta Crystallographica Section E (2011) 67, 2 o313-o314
a=12.8334(3)Å b=12.3560(2)Å c=9.3922(2)Å
α=90.00° β=105.965(2)° γ=90.00°
(2<i>E</i>)-3-(3-Bromo-4-methoxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one
C17H15BrO2
Acta Crystallographica Section E (2011) 67, 4 o1024
a=11.680(2)Å b=11.654(2)Å c=10.834(2)Å
α=90.00° β=93.07(2)° γ=90.00°
(2<i>E</i>)-3-(3,4-Dimethoxyphenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one
C17H16O4
Acta Crystallographica Section E (2011) 67, 4 o813
a=15.14350(10)Å b=8.43640(10)Å c=22.9454(2)Å
α=90.00° β=90.00° γ=90.00°
(2<i>E</i>)-3-(3-Bromo-4-methoxyphenyl)-1-(4-fluorophenyl)prop-2-en-1-one
C16H12BrFO2
Acta Crystallographica Section E (2011) 67, 5 o1090
a=11.056(2)Å b=4.1110(15)Å c=30.825(5)Å
α=90.00° β=96.76(2)° γ=90.00°
(2<i>E</i>)-3-[4-(1<i>H</i>-Benzimidazol-2-ylmethoxy)phenyl]- 1-(4-methoxyphenyl)prop-2-en-1-one
C24H20N2O3
Acta Crystallographica Section E (2011) 67, 5 o1088-o1089
a=7.2244(5)Å b=9.3201(8)Å c=14.9422(9)Å
α=98.449(2)° β=99.183(4)° γ=99.478(4)°
<i>N</i>-(4-Bromophenyl)-2-(naphthalen-1-yl)acetamide
C18H14BrNO
Acta Crystallographica Section E (2011) 67, 11 o2926-o2927
a=12.6837(11)Å b=9.4047(11)Å c=25.641(3)Å
α=90.00° β=90.00° γ=90.00°
(2<i>E</i>)-1-(2,5-Dimethoxyphenyl)-3-(3-nitrophenyl)prop-2-en-1-one
C17H15NO5
Acta Crystallographica Section E (2011) 67, 11 o3058-o3059
a=7.5015(5)Å b=7.9962(5)Å c=13.2468(8)Å
α=86.5070(10)° β=80.3420(10)° γ=76.3320(10)°
3-Fluoroanilinium 4-methylbenzenesulfonate
C6H7FN,C7H7O3S
Acta Crystallographica Section E (2011) 67, 11 o2924
a=14.5385(7)Å b=6.4939(3)Å c=14.5522(7)Å
α=90.00° β=91.429(4)° γ=90.00°
<i>N</i>-(3,5-Dichlorophenyl)-2-(naphthalen-1-yl)acetamide
C18H13Cl2NO
Acta Crystallographica Section E (2011) 67, 11 o2941-o2942
a=7.8090(14)Å b=24.811(4)Å c=9.6783(13)Å
α=90.00° β=125.050(10)° γ=90.00°
<i>N</i>-(4-Bromophenyl)-2-(4-chlorophenyl)acetamide
C14H11BrClNO
Acta Crystallographica Section E (2012) 68, 2 o519
a=15.584(8)Å b=4.763(3)Å c=18.139(10)Å
α=90.00° β=96.984(11)° γ=90.00°
(2<i>E</i>)-1-(3,4-Dichlorophenyl)-3-(2-hydroxyphenyl)prop-2-en-1-one
C15H10Cl2O2
Acta Crystallographica Section E (2012) 68, 2 o366
a=7.2551(6)Å b=7.8351(7)Å c=12.8049(11)Å
α=92.367(7)° β=102.946(8)° γ=109.011(8)°
1,3-Bis(biphenyl-4-yl)-2,2-dibromo-3-oxopropyl acetate
C29H22Br2O3
Acta Crystallographica Section E (2012) 68, 2 o362-o363
a=12.0497(14)Å b=20.842(2)Å c=9.9482(10)Å
α=90.00° β=98.743(10)° γ=90.00°
(2<i>E</i>)-1-(2,6-Dichloro-3-fluorophenyl)-3-(4-fluorophenyl)prop-2-en-1-one
C15H8Cl2F2O
Acta Crystallographica Section E (2012) 68, 2 o512
a=12.2311(3)Å b=10.3115(2)Å c=11.2468(3)Å
α=90.00° β=108.9350(10)° γ=90.00°
1-(2-Hydroxyethyl)-4-[3-(2-trifluoromethyl-9<i>H</i>-thioxanthen-9- ylidene)propyl]piperazine-1,4-diium dichloride
C23H27F3N2OS2,2(Cl)
Acta Crystallographica Section E (2011) 67, 8 o2079-o2080
a=34.1750(17)Å b=7.1613(3)Å c=22.6351(11)Å
α=90° β=115.307(6)° γ=90°
2-(4-Bromophenyl)-<i>N</i>-(pyrazin-2-yl)acetamide
C12H10BrN3O
Acta Crystallographica Section E (2013) 69, 6 o891
a=10.6804(4)Å b=7.5196(3)Å c=29.1355(10)Å
α=90° β=90° γ=90°
<i>N</i>-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)-2-(4-nitrophenyl)acetamide
C19H18N4O4
Acta Crystallographica Section E (2014) 70, 6 o636-o637
a=6.7023(6)Å b=8.6335(8)Å c=15.8720(13)Å
α=76.305(7)° β=84.399(7)° γ=77.252(7)°
(2<i>E</i>)-3-(3-Benzyloxyphenyl)-1-(2-hydroxy-5-methylphenyl)prop-2-en-1-one
C23H20O3
Acta Crystallographica Section E (2011) 67, 6 o1372-o1373
a=8.7308(5)Å b=9.5721(5)Å c=11.5286(6)Å
α=106.5470(10)° β=94.5720(10)° γ=101.6710(10)°
Cyclobenzaprinium salicylate
C20H22N,C7H5O3
Acta Crystallographica Section E (2011) 67, 7 o1584
a=7.4700(8)Å b=10.8408(12)Å c=14.9724(16)Å
α=76.073(2)° β=77.3570(10)° γ=72.574(2)°
Melitraceninium chloride
C21H26N,Cl
Acta Crystallographica Section E (2011) 67, 7 o1725
a=15.0129(18)Å b=8.8092(11)Å c=14.0135(17)Å
α=90.00° β=91.506(2)° γ=90.00°
4-(4-Chlorophenyl)-4-hydroxypiperidinium 2-(2-phenylethyl)benzoate
C11H15ClNO,C15H13O2
Acta Crystallographica Section E (2011) 67, 7 o1726
a=13.1016(2)Å b=10.2963(2)Å c=16.8015(3)Å
α=90.00° β=98.2340(10)° γ=90.00°
(2<i>E</i>)-1-(4,4''-Difluoro-5'-methoxy-1,1':3',1''-terphenyl-4'-yl)-3-(4-fluorophenyl)prop-2-en-1-one
C28H19F3O2
Acta Crystallographica Section E (2011) 67, 11 o2996-o2997
a=22.5742(5)Å b=6.81010(10)Å c=13.8475(3)Å
α=90.00° β=98.4050(10)° γ=90.00°
6-Fluoro-2-(4-methoxyphenyl)imidazo[2,1-<i>b</i>][1,3]benzothiazole
C16H11FN2OS
Acta Crystallographica Section E (2011) 67, 12 o3265-o3266
a=7.6120(13)Å b=13.883(2)Å c=13.049(2)Å
α=90.00° β=105.117(3)° γ=90.00°
4-Chloroanilinium 4-methylbenzenesulfonate
C6H7ClN,C7H7O3S
Acta Crystallographica Section E (2011) 67, 12 o3288-o3289
a=5.7253(5)Å b=7.5160(6)Å c=15.7642(13)Å
α=95.166(6)° β=96.148(7)° γ=92.353(7)°
1-[5-(4-Chlorophenyl)-3-(4-hydroxyphenyl)-4,5-dihydro-1<i>H</i>-pyrazol- 1-yl]ethanone
C17H15ClN2O2
Acta Crystallographica Section E (2012) 68, 3 o818
a=5.0213(2)Å b=15.6834(5)Å c=18.6368(6)Å
α=90.00° β=90.00° γ=90.00°
1-(6-Chloro-1,3-benzothiazol-2-yl)hydrazine
C7H6ClN3S
Acta Crystallographica Section E (2012) 68, 3 o691-o692
a=13.0225(13)Å b=5.7767(6)Å c=21.708(2)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-{2-[2,3-bis(methoxycarbonyl)guanido]-5-(phenylthio)phenyl}-\ 2-methoxyacetamide
C20H22N4O6S
Acta Crystallographica Section E (2012) 68, 3 o581-o582
a=10.6975(7)Å b=10.6921(7)Å c=18.3732(13)Å
α=90.00° β=91.0680(10)° γ=90.00°
Ethyl 2-amino-4,6-bis(4-fluorophenyl)cyclohexa-1,3-diene-1-carboxylate
C21H19F2NO2
Acta Crystallographica Section E (2012) 68, 3 o585
a=18.0199(5)Å b=9.6391(2)Å c=21.0754(7)Å
α=90.00° β=90.00° γ=90.00°
2-(2-Bromophenyl)acetic acid
C8H7BrO2
Acta Crystallographica Section E (2012) 68, 6 o1704
a=8.9732(5)Å b=5.9114(3)Å c=15.8489(7)Å
α=90.00° β=99.529(5)° γ=90.00°
Ethyl 2-amino-6-(4-bromophenyl)-4-(4-fluorophenyl)cyclohexa-1,3-diene-1-carboxylate
C21H19BrFNO2
Acta Crystallographica Section E (2013) 69, 9 o1473
a=9.4599(2)Å b=23.3634(5)Å c=17.2312(4)Å
α=90° β=96.001(2)° γ=90°
<i>N</i>-(1,3-Benzothiazol-2-yl)acetamide
C9H8N2OS
Acta Crystallographica Section E (2013) 69, 11 o1622
a=11.1852(4)Å b=7.4037(4)Å c=20.9189(8)Å
α=90° β=94.408(3)° γ=90°
(2<i>E</i>)-1-(4-Chlorophenyl)-3-[4-(propan-2-yl)phenyl]prop-2-en-1-one
C18H17ClO
Acta Crystallographica Section E (2014) 70, 8 o855
a=8.8547(5)Å b=5.8455(3)Å c=28.8034(17)Å
α=90° β=97.396(6)° γ=90°
(2<i>E</i>)-1-(2-Hydroxy-5-methylphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
C17H16O3
Acta Crystallographica Section E (2011) 67, 5 o1248-o1249
a=12.6990(18)Å b=8.8022(13)Å c=13.172(2)Å
α=90.00° β=105.565(2)° γ=90.00°
2,4-Bis(4-fluorophenyl)-2,3-dihydro-1<i>H</i>-1,5-benzodiazepine
C21H16F2N2
Acta Crystallographica Section E (2011) 67, 5 o1262-o1263
a=12.9151(4)Å b=6.0438(3)Å c=21.2851(7)Å
α=90° β=92.147(3)° γ=90°
(<i>E</i>)-3-(4-Chlorophenyl)-1-(4-fluorophenyl)prop-2-en-1-one
C15H10ClFO
Acta Crystallographica Section E (2012) 68, 3 o629
a=5.8875(3)Å b=7.4926(3)Å c=13.6022(6)Å
α=80.3510(10)° β=85.4830(10)° γ=83.5450(10)°
(6<i>Z</i>)-3,5-Bis(4-fluorophenyl)-6-(1-hydroxyethylidene)cyclohex-2-en-1-one
C20H16F2O2
Acta Crystallographica Section E (2012) 68, 3 o638-o639
a=17.663(2)Å b=6.2371(6)Å c=15.2357(16)Å
α=90.00° β=107.717(13)° γ=90.00°
Ethyl ({5-[5'-(2-ethoxy-2-oxoethoxy)-4,4''-difluoro-1,1':3',1''-terphenyl- 4'-yl]-1,3,4-oxadiazol-2-yl}sulfanyl)acetate
C28H24F2N2O6S
Acta Crystallographica Section E (2012) 68, 3 o674-o675
a=8.2721(8)Å b=10.2740(10)Å c=16.2342(16)Å
α=81.058(2)° β=82.987(2)° γ=83.646(2)°
(<i>E</i>)-1-(4,4''-Difluoro-5'-methoxy-1,1':3',1''-terphenyl-4'-yl)-3-(4-methylphenyl)prop-2-en-1-one
C29H22F2O2
Acta Crystallographica Section E (2011) 67, 12 o3181-o3182
a=6.9020(3)Å b=11.3965(6)Å c=14.8362(8)Å
α=96.177(2)° β=93.381(2)° γ=106.446(2)°
(<i>E</i>)-1-(4,4''-Difluoro-5'-methoxy-1,1':3',1''-terphenyl-4'-yl)-3-(4-nitrophenyl)prop-2-en-1-one
C28H19F2NO4
Acta Crystallographica Section E (2011) 67, 12 o3179-o3180
a=23.3751(7)Å b=6.9098(2)Å c=13.7879(5)Å
α=90.00° β=99.243(2)° γ=90.00°
2,2'-(Disulfanediyl)bis[4,6-(4-fluorophenyl)pyrimidine]
C32H18F4N4S2
Acta Crystallographica Section E (2012) 68, 2 o476-o477
a=9.3371(2)Å b=11.3093(3)Å c=13.1984(3)Å
α=102.3640(10)° β=93.0940(10)° γ=94.0100(10)°
Methyl 3,5-dibromo-2-diacetylaminobenzoate
C12H11Br2NO4
Acta Crystallographica Section E (2011) 67, 9 o2503
a=7.6386(8)Å b=8.8870(6)Å c=10.8691(8)Å
α=78.186(6)° β=76.155(7)° γ=82.750(7)°
<i>N</i>'-(2,6-Difluorobenzylidene)pyridine-4-carbohydrazide
C13H9F2N3O
Acta Crystallographica Section E (2012) 68, 5 o1484
a=6.84620(10)Å b=24.7903(5)Å c=8.37190(10)Å
α=90.00° β=125.2490(10)° γ=90.00°
4-[(4-Benzyloxybenzylidene)amino]-1,5-dimethyl-2-phenyl- 1<i>H</i>-pyrazol-3(2<i>H</i>)-one
C25H23N3O2
Acta Crystallographica Section E (2012) 68, 5 o1324
a=19.8137(19)Å b=6.1588(4)Å c=18.0784(14)Å
α=90.00° β=108.881(9)° γ=90.00°
<i>N</i>-(2,4-Dimethylphenyl)-2,2-diphenylacetamide
C22H21NO
Acta Crystallographica Section E (2012) 68, 5 o1316-o1317
a=9.5520(9)Å b=10.2011(10)Å c=17.9656(17)Å
α=91.030(2)° β=98.957(2)° γ=90.377(2)°
4-[(1<i>E</i>)-3-(2,6-Dichloro-3-fluorophenyl)-3-oxoprop-1-en-1-yl]benzonitrile
C16H8Cl2FNO
Acta Crystallographica Section E (2012) 68, 5 o1413
a=13.2751(3)Å b=8.5002(2)Å c=13.9854(3)Å
α=90.00° β=116.7730(10)° γ=90.00°
(2<i>E</i>)-1-(4,4''-Difluoro-5'-methoxy-1,1':3',1''-terphenyl-4'-yl)-3-(2- fluorophenyl)prop-2-en-1-one
C28H19F3O2
Acta Crystallographica Section E (2012) 68, 7 o2024
a=13.75920(10)Å b=6.78980(10)Å c=22.4361(3)Å
α=90.00° β=101.9080(10)° γ=90.00°
<i>N</i>'-[(<i>E</i>)-4-Chlorobenzylidene]pyridine-4-carbohydrazide monohydrate
C13H10ClN3O,H2O
Acta Crystallographica Section E (2012) 68, 7 o2303-o2304
a=14.1645(7)Å b=14.6276(7)Å c=14.0817(7)Å
α=90.00° β=119.220(2)° γ=90.00°
(1<i>Z</i>)-1-[(2<i>E</i>)-3-(4-Bromophenyl)-1-(4-fluorophenyl)prop-2-en-1- ylidene]-2-(2,4-dinitrophenyl)hydrazine
C21H14BrFN4O4
Acta Crystallographica Section E (2012) 68, 7 o2193
a=15.0738(12)Å b=10.6511(5)Å c=14.3353(8)Å
α=90.00° β=116.010(9)° γ=90.00°
(1<i>E</i>,4<i>E</i>)-1-(3-Nitrophenyl)-5-phenylpenta-1,4-dien-3-one
C17H13NO3
Acta Crystallographica Section E (2012) 68, 1 o74-o75
a=11.9806(6)Å b=9.8955(4)Å c=12.5562(7)Å
α=90° β=114.992(7)° γ=90°
(2<i>E</i>)-2-[(3<i>E</i>)-4-Phenylbut-3-en-2-ylidene]hydrazinecarboxamide
C11H13N3O
Acta Crystallographica Section E (2012) 68, 1 o76-o77
a=15.1094(8)Å b=24.4445(11)Å c=7.0368(4)Å
α=90° β=109.908(6)° γ=90°
2-(2,4-Dichlorophenyl)-<i>N</i>-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro- 1<i>H</i>-pyrazol-4-yl)acetamide
C19H17Cl2N3O2
Acta Crystallographica Section E (2013) 69, 1 o39
a=25.1853(5)Å b=8.18108(9)Å c=21.0978(4)Å
α=90.00° β=119.772(3)° γ=90.00°
4-(4-Iodoanilino)-2-methylene-4-oxobutanoic acid
C11H10INO3
Acta Crystallographica Section E (2013) 69, 1 o83
a=23.1111(6)Å b=4.78630(10)Å c=10.4262(2)Å
α=90.00° β=97.0710(10)° γ=90.00°
2-(2,6-Dichlorophenyl)-<i>N</i>-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro- 1<i>H</i>-pyrazol-4-yl)acetamide
C19H17Cl2N3O2
Acta Crystallographica Section E (2013) 69, 1 o46-o47
a=20.3442(11)Å b=12.1080(8)Å c=14.9500(8)Å
α=90.00° β=93.837(5)° γ=90.00°
6-(3-Chlorophenyl)imidazo[2,1-<i>b</i>][1,3,4]thiadiazole
C10H6ClN3S
Acta Crystallographica Section E (2013) 69, 1 o66
a=5.43804(19)Å b=12.4222(4)Å c=14.1684(4)Å
α=90.00° β=100.269(3)° γ=90.00°
4-[(<i>E</i>)-(4-Benzyloxybenzylidene)amino]-1,5-dimethyl-2-phenyl- 1<i>H</i>-pyrazol-3(2<i>H</i>)-one
C25H23N3O2
Acta Crystallographica Section E (2013) 69, 1 o115
a=13.0079(5)Å b=9.9079(4)Å c=17.0469(9)Å
α=90.00° β=103.674(4)° γ=90.00°
3-Chloro-4-fluoroanilinium picrate
C6H6ClF,C6H2N3O7
Acta Crystallographica Section E (2013) 69, 2 o240
a=4.4054(2)Å b=11.9881(5)Å c=13.7010(5)Å
α=90.0570(10)° β=91.8030(10)° γ=97.7430(10)°
4-[(<i>E</i>)-(4-Hydroxybenzylidene)amino]-3-methyl-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C10H10N4OS
Acta Crystallographica Section E (2014) 70, 6 o733-o734
a=5.7677(5)Å b=7.7233(8)Å c=12.7269(12)Å
α=84.104(8)° β=77.719(8)° γ=73.358(9)°
3-(4-Fluorobenzoyl)-4-(4-fluorophenyl)-4-hydroxy-2,6-diphenylcyclohexane-1,1-dicarbonitrile
C33H24F2N2O2
Acta Crystallographica Section E (2014) 70, 6 o736-o737
a=10.9336(10)Å b=11.5258(4)Å c=11.8490(7)Å
α=89.440(4)° β=62.687(7)° γ=89.296(5)°
2-(2-Methylphenyl)-<i>N</i>-(1,3-thiazol-2-yl)acetamide
C12H12N2OS
Acta Crystallographica Section E (2014) 70, 6 o716
a=17.6983(6)Å b=4.94078(13)Å c=14.4603(5)Å
α=90° β=111.236(4)° γ=90°
4-[(4-Acetylphenyl)amino]-2-methylidene-4-oxobutanoic acid
C13H13NO4
Acta Crystallographica Section E (2014) 70, 7 o752-o753
a=5.0164(5)Å b=5.2908(4)Å c=21.8464(18)Å
α=92.833(6)° β=90.315(7)° γ=96.222(7)°
1-{3-(4-Chlorophenyl)-5-[4-(propan-2-yl)phenyl]-4,5-dihydro-1<i>H</i>-pyrazol-1-yl}butan-1-one
C22H25ClN2O
Acta Crystallographica Section E (2014) 70, 7 o761-o762
a=6.8148(6)Å b=11.1115(9)Å c=13.8239(15)Å
α=70.935(9)° β=81.420(8)° γ=75.829(7)°
1-{3-(4-Chlorophenyl)-5-[4-(propan-2-yl)phenyl]-4,5-dihydro-1<i>H</i>-pyrazol-1-yl}propan-1-one
C21H23ClN2O
Acta Crystallographica Section E (2014) 70, 7 o763-o764
a=6.6042(3)Å b=10.1188(9)Å c=14.4806(12)Å
α=98.444(7)° β=90.650(6)° γ=106.542(6)°
4-[(4-Bromophenyl)amino]-2-methylidene-4-oxobutanoic acid
C11H10BrNO3
Acta Crystallographica Section E (2014) 70, 7 o779-o780
a=6.2782(4)Å b=8.3251(5)Å c=21.3244(12)Å
α=96.462(5)° β=92.026(5)° γ=95.390(5)°
1-{3-(4-Chlorophenyl)-5-[4-(propan-2-yl)phenyl]-4,5-dihydro-1<i>H</i>-pyrazol-1-yl}ethanone
C20H21ClN2O
Acta Crystallographica Section E (2014) 70, 7 o781
a=6.4836(6)Å b=9.6524(9)Å c=14.4390(10)Å
α=81.178(7)° β=89.720(7)° γ=77.488(8)°
4,6-Bis(4-fluorophenyl)-2-phenyl-1<i>H</i>-indazol-3(2<i>H</i>)-one
C25H16F2N2O
Acta Crystallographica Section E (2011) 67, 6 o1346-o1347
a=15.2947(4)Å b=11.6259(2)Å c=20.9388(5)Å
α=90° β=90° γ=90°
(2<i>E</i>)-3-[3-(Benzyloxy)phenyl]-1-(2-hydroxyphenyl)prop-2-en-1-one
C22H18O3
Acta Crystallographica Section E (2011) 67, 6 o1313-o1314
a=6.63430(10)Å b=35.7706(5)Å c=8.15370(10)Å
α=90.00° β=121.8790(10)° γ=90.00°
(1<i>E</i>,2<i>E</i>)-1,2-Bis(3-bromo-4-methoxybenzylidene)hydrazine
C16H14Br2N2O2
Acta Crystallographica Section E (2011) 67, 6 o1379
a=10.1354(8)Å b=10.5500(10)Å c=15.6055(12)Å
α=90.00° β=96.680(7)° γ=90.00°
3,5-Bis(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazole-1-carbaldehyde
C16H12F2N2O
Acta Crystallographica Section E (2011) 67, 6 o1292-o1293
a=6.2141(9)Å b=6.7802(8)Å c=17.9857(9)Å
α=96.727(4)° β=90.254(4)° γ=116.791(5)°
Opipramol
C23H29N3O
Acta Crystallographica Section E (2011) 67, 7 o1598
a=12.6215(2)Å b=10.5929(2)Å c=14.3629(2)Å
α=90.00° β=90.9660(10)° γ=90.00°
<i>N</i>-(3-Chloro-4-fluorophenyl)-2-(naphthalen-1-yl)acetamide
C18H13ClFNO
Acta Crystallographica Section E (2011) 67, 7 o1826
a=8.096(6)Å b=23.323(6)Å c=8.404(3)Å
α=90.00° β=110.83(5)° γ=90.00°
3,5-Bis(4-methoxyphenyl)-4,5-dihydroisoxazole
C17H17NO3
Acta Crystallographica Section E (2011) 67, 8 o1975-o1976
a=10.5071(7)Å b=8.4023(5)Å c=32.6662(19)Å
α=90° β=90° γ=90°
1,3-Bis(4-fluorophenyl)-<i>N</i>,<i>N</i>'-(propane-1,3- diylidene)dihydroxylamine
C15H12F2N2O2
Acta Crystallographica Section E (2011) 67, 8 o1954-o1955
a=9.9233(7)Å b=10.4236(6)Å c=13.2422(11)Å
α=86.419(6)° β=79.205(7)° γ=89.932(5)°
Methyl (2<i>Z</i>)-2-(2-fluoro-4-methoxybenzylidene)-5-(4-methoxyphenyl)- 7-methyl-3-oxo-2,3-dihydro-5<i>H</i>-[1,3]thiazolo[3,2-<i>a</i>]pyrimidine- 6-carboxylate
C24H21FN2O5S
Acta Crystallographica Section E (2011) 67, 8 o1913-o1914
a=11.7374(2)Å b=14.3062(2)Å c=14.5552(2)Å
α=61.9390(10)° β=80.7910(10)° γ=84.8780(10)°
4-(1<i>H</i>-Benzimidazol-2-ylmethoxy)-3-methoxybenzaldehyde tetrahydrate
C16H14N2O3,4(H2O)
Acta Crystallographica Section E (2011) 67, 8 o2021-o2022
a=6.8953(6)Å b=11.4266(13)Å c=11.7287(14)Å
α=107.965(10)° β=90.906(8)° γ=91.769(8)°
<i>N</i>,<i>N</i>-Dimethyl-3-oxo-3-(thiophen-2-yl)propanaminium chloride
C9H14NOS,Cl
Acta Crystallographica Section E (2011) 67, 9 o2271
a=5.8663(3)Å b=27.0109(9)Å c=7.1385(4)Å
α=90.00° β=110.767(6)° γ=90.00°
[3-(5-Hydroxy-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>]cyclohepten-5- yl)propyl]dimethylammonium 3-carboxyprop-2-enoate
C20H24NO,C4H3O4
Acta Crystallographica Section E (2011) 67, 10 o2600-o2601
a=9.2115(2)Å b=11.5840(2)Å c=10.4640(2)Å
α=90.00° β=101.591(2)° γ=90.00°
<i>N</i>-(4-Chloro-1,3-benzothiazol-2-yl)-2-(3-methylphenyl)acetamide monohydrate
C16H13ClN2OS,H2O
Acta Crystallographica Section E (2011) 67, 10 o2602-o2603
a=7.2771(3)Å b=9.2568(5)Å c=12.0851(5)Å
α=83.948(4)° β=84.306(3)° γ=72.133(4)°
2,3-Dibromo-3-(4-chlorophenyl)-1-(2-hydroxyphenyl)propan-1-one
C15H11Br2ClO2
Acta Crystallographica Section E (2011) 67, 10 o2651-o2652
a=29.075(3)Å b=9.2358(10)Å c=11.4374(12)Å
α=90.00° β=103.290(2)° γ=90.00°
4,4'-Difluorobenzhydryl piperazinium picrate
C17H19F2N2,C6H2N3O7
Acta Crystallographica Section E (2011) 67, 10 o2587-o2588
a=8.9425(2)Å b=11.8286(2)Å c=23.0922(4)Å
α=90.00° β=105.7200(10)° γ=90.00°
<i>N</i>-(3-Chloro-4-fluorophenyl)-2,2-diphenylacetamide
C20H15ClFNO
Acta Crystallographica Section E (2011) 67, 10 o2604
a=9.3665(17)Å b=10.2069(12)Å c=9.7774(16)Å
α=90.00° β=114.42(2)° γ=90.00°
3-Chloroanilinium 4-methylbenzenesulfonate
C6H7ClN,C7H7O3S
Acta Crystallographica Section E (2011) 67, 11 o2925
a=12.7848(3)Å b=6.7767(2)Å c=16.1702(4)Å
α=90.00° β=105.081(2)° γ=90.00°
5-(4,4''-Difluoro-5'-hydroxy-1,1':3',1''-terphenyl-4'-yl)-3-(morpholin-4- ylmethyl)-1,3,4-oxadiazole-2(3<i>H</i>)-thione
C25H21F2N3O3S
Acta Crystallographica Section E (2011) 67, 12 o3372
a=16.0547(14)Å b=11.4125(11)Å c=25.364(2)Å
α=90.00° β=94.202(2)° γ=90.00°
Methyl 2,4-bis(4-fluorophenyl)-6-methoxybenzoate
C21H16F2O3
Acta Crystallographica Section E (2011) 67, 12 o3390
a=8.12700(10)Å b=9.46810(10)Å c=22.3297(3)Å
α=90.00° β=90.00° γ=90.00°
(2<i>E</i>)-3-(3-Bromo-4-methoxyphenyl)-1-(4,4''-difluoro-5'-methoxy- 1,1':3',1''-terphenyl-4'-yl)prop-2-en-1-one
C29H21BrF2O3
Acta Crystallographica Section E (2011) 67, 12 o3514
a=9.6902(6)Å b=20.3345(12)Å c=12.9556(8)Å
α=90.00° β=110.6360(10)° γ=90.00°
(<i>E</i>)-1-(4,4''-Difluoro-5'-methoxy-1,1':3',1''-terphenyl-4'-yl)- 3-(6-methoxynaphthalen-2-yl)prop-2-en-1-one
C33H24F2O3
Acta Crystallographica Section E (2011) 67, 12 o3327-o3328
a=6.9524(5)Å b=33.024(2)Å c=11.6030(9)Å
α=90.00° β=107.2670(10)° γ=90.00°
(<i>E</i>)-1-(4,4''-Difluoro-5'-methoxy-1,1':3',1''-terphenyl-4'-yl)-3-(4-methoxyphenyl)prop-2-en-1-one
C29H22F2O3
Acta Crystallographica Section E (2011) 67, 12 o3323-o3324
a=9.6059(2)Å b=19.2236(5)Å c=13.3772(3)Å
α=90.00° β=112.9050(10)° γ=90.00°
(<i>E</i>)-1-(4,4''-Difluoro-5'-methoxy-1,1':3',1''-terphenyl-4'-yl)-3-phenylprop-2-en-1-one
C28H20F2O2
Acta Crystallographica Section E (2011) 67, 12 o3159-o3160
a=13.9226(4)Å b=6.7977(2)Å c=22.4531(7)Å
α=90.00° β=101.8740(10)° γ=90.00°
1,2-Bis(3-phenoxybenzylidene)hydrazine
C26H20N2O2
Acta Crystallographica Section E (2012) 68, 1 o81
a=23.6271(16)Å b=11.2942(6)Å c=8.2359(7)Å
α=90.00° β=109.538(8)° γ=90.00°
<i>N</i>-(4,6-Dimethoxypyrimidin-2-yl)-2-(3-methylphenyl)acetamide
C15H17N3O3
Acta Crystallographica Section E (2012) 68, 1 o226-o227
a=7.1536(6)Å b=8.2070(7)Å c=13.8259(10)Å
α=74.420(7)° β=86.540(6)° γ=69.186(8)°
1-(4,4''-Difluoro-5'-methoxy-1,1':3',1''-terphenyl-4'-yl)ethanone
C21H16F2O2
Acta Crystallographica Section E (2012) 68, 1 o163
a=6.0816(7)Å b=25.997(3)Å c=10.9061(12)Å
α=90.00° β=100.866(2)° γ=90.00°
Ethyl 4,4''-difluoro-5'-methoxy-1,1':3',1''-terphenyl-4'-carboxylate
C22H18F2O3
Acta Crystallographica Section E (2012) 68, 1 o172
a=8.5197(11)Å b=9.5225(12)Å c=22.871(3)Å
α=90.00° β=90.00° γ=90.00°
1,2-Bis[(1,3-benzodioxol-5-yl)methylidene]hydrazine
C16H12N2O4
Acta Crystallographica Section E (2012) 68, 1 o7
a=6.1835(2)Å b=4.5970(2)Å c=23.8487(10)Å
α=90.00° β=96.080(4)° γ=90.00°
2-[3,5-Bis(4-fluorophenyl)-4,5-dihydro-1<i>H</i>-pyrazol-1-yl]- 4,6-bis(4-fluorophenyl)pyrimidine
C31H20F4N4
Acta Crystallographica Section E (2012) 68, 3 o807-o808
a=10.10200(10)Å b=10.11060(10)Å c=12.38860(10)Å
α=104.7190(10)° β=98.2750(10)° γ=102.1670(10)°
1-[3-(4-Chlorophenyl)-5-(4-methoxyphenyl)-4,5-dihydro-1<i>H</i>-pyrazol- 1-yl]ethanone
C18H17ClN2O2
Acta Crystallographica Section E (2012) 68, 4 o1023
a=9.3473(4)Å b=9.4418(4)Å c=19.7840(7)Å
α=90.00° β=113.830(2)° γ=90.00°
(2<i>E</i>)-3-(3-Nitrophenyl)-1-[4-(piperidin-1-yl)phenyl]prop-2-en-1-one
C20H20N2O3
Acta Crystallographica Section E (2012) 68, 4 o974
a=7.4268(12)Å b=11.3884(18)Å c=39.447(6)Å
α=90.00° β=90.00° γ=90.00°
Triprolidinium dichloranilate--chloranilic acid--methanol--water (2/1/2/2)
C19H24N22,2(C6HCl2O4),0.5(C6H2Cl2O4),CH4O,H2O
Acta Crystallographica Section E (2012) 68, 4 o1037-o1038
a=9.1633(2)Å b=32.3720(7)Å c=12.9834(4)Å
α=90° β=106.685(3)° γ=90°